peptide V

isolated from bovine posterior pituitary; 94% identical with the carboxyl terminus of rat VGF protein; composed of 30 amino acids; amino acid sequence given in first source

Also Known As:

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Davidge, Sandra T: 1 article (06/2022)
2.	Fan, Hongbing: 1 article (06/2022)
3.	Liao, Wang: 1 article (06/2022)
4.	Wu, Jianping: 1 article (06/2022)
5.	Dunbar, Jana G: 1 article (01/2013)
6.	Glisson, Renee: 1 article (01/2013)
7.	Kleindienst, Andrea: 1 article (01/2013)
8.	Marmarou, Anthony: 1 article (01/2013)
9.	Chini, Bice: 1 article (01/2008)
10.	Durroux, Thierry: 1 article (01/2008)

Related Diseases

1.	Hyponatremia 01/01/2008 - "While a number of orally active non-peptide V(2) antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed V(2)/V(1a), antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients. "
2.	Inflammation (Inflammations) 06/01/2022 - "The regulation of peptide V-F on vascular inflammation supported its functional food or nutraceutical application in the prevention and treatment of hypertension and cardiovascular diseases."
3.	Hypotension (Low Blood Pressure) 01/01/2013 - "Male Sprague-Dawley rats were randomly assigned to a continuous infusion of vehicle (1 % DMSO) or the selective non-peptide V(1A) antagonist SR49059 (83nM = 1 mg/kg) starting before controlled cortical impact (CCI) injury plus hypoxia and hypotension (HH, 30 min), or middle cerebral artery (MCA) occlusion (2 h + 2 h reperfusion). "
4.	Hypertension (High Blood Pressure) 06/01/2022 - "The regulation of peptide V-F on vascular inflammation supported its functional food or nutraceutical application in the prevention and treatment of hypertension and cardiovascular diseases."
5.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/01/1992 - "Lewis rats immunized with T cell receptor (TCR) variable region peptide V beta 8 in complete Freund's adjuvant (CFA) were protected against experimental autoimmune encephalomyelitis (EAE) induced with myelin basic protein in CFA, although variable protection was also observed in rats injected with control peptide in CFA, or CFA alone. "

Related Drugs and Biologics

1.	Tolvaptan
2.	lixivaptan
3.	conivaptan (Vaprisol)
4.	satavaptan
5.	T-Cell Antigen Receptors (T-Cell Receptor)
6.	Peptides (Polypeptides)
7.	Freund's Adjuvant
8.	Myelin Basic Protein
9.	Dimethyl Sulfoxide (DMSO)